| Record ID | marc_columbia/Columbia-extract-20221130-012.mrc:83703689:4485 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-012.mrc:83703689:4485?format=raw |
LEADER: 04485cam a22005174a 4500
001 5591076
005 20221121190327.0
008 050428s2005 enka b 001 0 eng
010 $a 2005012018
016 7 $a101263888$2DNLM
020 $a0521854962
024 3 $a9780521854962
029 1 $aNLM$b101263888
035 $a(OCoLC)ocm60028983
035 $a(NNC)5591076
035 $a5591076
040 $aDLC$cDLC$dYDX$dBAKER$dVVC$dNLM$dIXA
042 $apcc
050 00 $aHD9665.5$b.E85 2005
060 00 $a2005 O-341
060 10 $aQV 736$bE848 2005
082 00 $a338.4/76151$222
245 00 $aEthics and the pharmaceutical industry /$cedited by Michael A. Santoro, Thomas M. Gorrie.
260 $aCambridge ;$aNew York, NY :$bCambridge University Press,$c2005.
300 $axxxiv, 492 pages :$billustrations ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 0 $aDrug research: between ethical demands and economic constraints / Jürgen Drews -- Emerging international norms for clinical testing: good clinical trial practice / Juhana E. Idänpään-Heikkilä, Sev Fluss -- The regulatory and ethical challenges of pediatric research / M. Dianne Murphy, Sara F. Goldkind -- Including children in research: participation or exploitation? / Robert M. Nelson -- Racial and ethnic inclusiveness in clinical trials / Valentine J. Burroughs -- The rights of patients to participate in clinical research / Glenna M. Crooks -- How should government regulate stem-cell research? views from a scientist-legislator / Rush Holt -- Ethics and prescribing: the clinician's perspective / Charles L. Bardes -- The regulation of prescription drug promotion / Thomas Abrams --
505 0 $aDirect-to-consumer advertising of prescription drugs: a policy dilemma / Meredith B. Rosenthal, Julie M. Donohue -- Off-label communications and prescription drugs / Schott D. Danzis -- The need for better health information: advancing the informed patient in Europe / Don E. Detmer, Peter Singleton, Scott C. Ratzan -- Who should get access to which drugs? an ethical template for pharmacy benefits / Norman Daniels, James E. Sabin, J. Russell Teagarden -- The application of cost-effectiveness and cost-benefit analysis to pharmaceuticals / Joel W. Hay -- Intellectual property rights, access to life-enhancing drugs, and corporate moral responsibilities / Patricia H. Werhande, Michael E. Gorman --
505 0 $aA future agenda for government-industry relations / William C. Weldon -- AIDS activism and the pharmaceutical industry / Martin Delaney -- The campaign against innovation / Sidney Taurel -- Third world perspectives on global pharmaceutical access / James Thuo Gathii -- The promise of vaccines and the influenza vaccine shortage of 2004: public and private partnerships / Gary R. Noble -- Evolving approaches to healthcare challenges / Thomas M. Gorrie -- Property rights in crisis: managers and rescue / Nien-hê Hsieh -- Blurring the lines: public and private partnerships addressing global health / William H. Foege -- Renegotiating the grand bargain: balancing prices, profits, people, and principles / Edward Greg Koski.
650 0 $aPharmaceutical industry.$0http://id.loc.gov/authorities/subjects/sh85039713
650 0 $aDrugs$xMarketing$xMoral and ethical aspects.
650 0 $aDrugs$xResearch$xMoral and ethical aspects.
650 0 $aMedical innovations$xSocial aspects.$0http://id.loc.gov/authorities/subjects/sh85082947
650 0 $aSocial responsibility of business.$0http://id.loc.gov/authorities/subjects/sh90005735
650 12 $aDrug Industry$xethics.$0https://id.nlm.nih.gov/mesh/D004345Q000941
650 12 $aDrug Industry$xorganization & administration.$0https://id.nlm.nih.gov/mesh/D004345Q000458
650 22 $aEthics, Business.$0https://id.nlm.nih.gov/mesh/D040861
650 22 $aSocial Responsibility.$0https://id.nlm.nih.gov/mesh/D012941
650 22 $aTechnology, Pharmaceutical$xethics.$0https://id.nlm.nih.gov/mesh/D013678Q000941
700 1 $aSantoro, Michael A.$0http://id.loc.gov/authorities/names/n99282217
700 1 $aGorrie, Thomas M.$0http://id.loc.gov/authorities/names/n2005031443
856 41 $3Table of contents$uhttp://www.loc.gov/catdir/toc/ecip0511/2005012018.html
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/enhancements/fy0633/2005012018-d.html
852 00 $boff,hsl$hHD9665.5$i.E85 2005